1. Bremer J. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 1990;28:297–301.
2. Chalmers RA, Stanley CA, English N, Wigglesworth JS. Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death. J Pediatr 1997;131:220–225.
3. Lee NC, Tang NL, Chien YH, Chen CA, Lin SJ, Chiu PC, et al. Diagnoses of newborns and mothers with carnitine uptake defects through newborn screening. Mol Genet Metab 2010;100:46–50.
4. Cano A, Ovaert C, Vianey-Saban C, Chabrol B. Carnitine membrane transporter deficiency: a rare treatable cause of cardiomyopathy and anemia. Pediatr Cardiol 2008;29:163–165.
5. Niu DM, Chien YH, Chiang CC, Ho HC, Hwu WL, Kao SM, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan. J Inherit Metab Dis 2010;33(Suppl 2): S295–S305.
6. Koizumi A, Nozaki J, Ohura T, Kayo T, Wada Y, Nezu J, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet 1999;8:2247–2254.
7. Wilcken B, Wiley V, Sim KG, Carpenter K. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr 2001;138:581–584.
8. Schulze A, Lindner M, Kohlmüller D, Olgemöller K, Mayatepek E, Hoffmann GF. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics 2003;111(6 Pt 1): 1399–1406.
9. Schimmenti LA, Crombez EA, Schwahn BC, Heese BA, Wood TC, Schroer RJ, et al. Expanded newborn screening identifies maternal primary carnitine deficiency. Mol Genet Metab 2007;90:441–445.
10. Matsuo M, Saiki K, Momota T, Ishida A, Kanazawa K, Murakami R, et al. Transient carnitine-responsive medium-chain dicarboxylic aciduria in an infant with cholestasis, hypoglycemia and cardiac failure. Acta Paediatr Jpn 1989;31:211–215.
11. Amat di San Filippo C, Taylor MR, Mestroni L, Botto LD, Longo N. Cardiomyopathy and carnitine deficiency. Mol Genet Metab 2008;94:162–166.
12. Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet 2006;142C:77–85.
13. Stanley CA, DeLeeuw S, Coates PM, Vianey-Liaud C, Divry P, Bonnefont JP, et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake. Ann Neurol 1991;30:709–716.
14. Stanley CA, Bennett MJ, Mayatepek E. Fernandes J, Saudubray JM, van Den Berghe G, Walter JH,Disorders of fatty acid oxidation and related metabolic pathways. editors. Inborn metabolic diseases: diagnosis and treatment. 2006;4th ed. Heidelberg: Springer, :177–188.
15. de Vries Y, Arvidson DN, Waterham HR, Cregg JM, Woldegiorgis G. Functional characterization of mitochondrial carnitine palmitoyltransferases I and II expressed in the yeast Pichia pastoris. Biochemistry 1997;36:5285–5292.
16. Hwu WL, Chiang SC, Chang MH, Wang TR. Carnitine transport defect presenting with hyperammonemia: report of one case. Acta Paediatr Taiwan 2000;41:36–38.
17. Ogier de BH, Superti-Furga A. Blau N, Hoffman GF, Leonard JV, Clarke JT,Disorders of mitochondrial fatty acid oxidation and ketone body metabolism. editors. Physician's guide to the treatment and follow-up of metabolic disease. 2006;Berlin: Springer, :147–160.
18. Evangeliou A, Vlassopoulos D. Carnitine metabolism and deficit--when supplementation is necessary? Curr Pharm Biotechnol 2003;4:211–219.
19. Chiong MA, Sim KG, Carpenter K, Rhead W, Ho G, Olsen RK, et al. Transient multiple acyl-CoA dehydrogenation deficiency in a newborn female caused by maternal riboflavin deficiency. Mol Genet Metab 2007;92:109–114.